Century Therapeutics, Inc. (IPSC) Institutional Ownership

Ownership Summary

Century Therapeutics, Inc. (NASDAQ:IPSC) appears in 71 institutional 13F filings for the quarter ending March 2026.

• They owned 71.0% of outstanding stock in March 2026, up from 29.6% the prior quarter.
• Their total shares held in IPSC increased 530.02% quarter over quarter, and separately, investors owning Century Therapeutics stayed flat from a year ago.
• Among the 71 funds, 49 bought more Century Therapeutics shares, 11 sold down, and 11 held their ground.
• Altogether, these fund groups held 137.35Mn shares in IPSC by March 2026, up by 115.55Mn shares quarter on quarter, and up 106.86Mn shares year over year.
• As of March 31, 2026, RA CAPITAL MANAGEMENT, L.P. held the largest stake in Century Therapeutics with 17.75Mn shares, accounting for 9.18% of total shares outstanding.
• Leading buyers of Century Therapeutics shares for the quarter ending March 2026 were RA CAPITAL MANAGEMENT, L.P. (17.75Mn), TCG Crossover Management, LLC (17.75Mn), Versant Venture Management, LLC (12.17Mn), Deep Track Capital, LP (9.49Mn), RTW INVESTMENTS, LP (8.7Mn).
• Leading sellers of Century Therapeutics shares for the quarter ending March 2026 were ACADIAN ASSET MANAGEMENT LLC (939.03K), RENAISSANCE TECHNOLOGIES LLC (442.37K), DAFNA Capital Management LLC (359.23K), SUPERSTRING CAPITAL MANAGEMENT LP (343.66K), GSA CAPITAL PARTNERS LLP (256.36K).
• Century Therapeutics's 10 largest shareholders as of March 2026 include RA CAPITAL MANAGEMENT, L.P. (17.75Mn), TCG Crossover Management, LLC (17.75Mn), Versant Venture Management, LLC (12.17Mn), Deep Track Capital, LP (9.49Mn), RTW INVESTMENTS, LP (8.7Mn), Commodore Capital LP (8.7Mn), Venrock Adviser, LLC (8.7Mn), Point72 Asset Management, L.P. (5.96Mn), VANGUARD CAPITAL MANAGEMENT LLC (5.69Mn), BALYASNY ASSET MANAGEMENT L.P. (5.02Mn) per Business Quant data.